Company Profile
GC Medical Science is a diagnostic medical device company in the vitro diagnostic industry in South Korea and globally. The company's products include human healthcare products for the diagnosis of diabetes, non-communicable diseases, respiratory diseases, and vector borne diseases.
It offers CERA-CHEK 1Code and CERA-CHEK 1070 for diabetes. Its portfolio also includes GREENCARE A1c for HbA1c, CERA-CHEK 3 in 1 GHL for multi-diagnosis, CERA-CHEK Lactate, GREENCARE Hb and CERA-CHEK Hb Plus for haemoglobin, and GCare Lipid and GCare Lipid Printer for cholesterol Covid-19 and flu diagnosis equipment including GENEDIA W Covid-19 Ag, GreenCare FLU2 Influenza A&B Ag, and ย GENEDIA W Covid-19 & Flu A&B Ag.
Additionally, it offers dengue diagnosis equipment including GENEDIA W Dengue NS1 Ag, GENEDIA W Dengue lgM/lgG Ab, and GENEDIA W Dengue NS1 & lgM/lgG Combo vet healthcare products, such as CERA-PET blood glucose monitoring system for diabetes; and CERA-PET Multi for non-communicable diseases diagnosis. Founded in 1972 and headquartered in Yongin-Si, South Korea, GC Medical Science was formerly known as Green Cross Medical Science Corporation before rebranding in May 2026.